Related Experiment Video
Updated: Jul 4, 2025

Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
SIRT1 and thrombosis
Alessandra Bettiol1, Maria Letizia Urban1, Giacomo Emmi1
1Department of Experimental and Clinical Medicine, University of Firenze, Firenze, Italy.
Insights
Sirtuin 1 (SIRT1) is crucial in regulating thrombosis by influencing inflammation and blood clotting. Targeting SIRT1 shows therapeutic potential for preventing thrombosis, as supported by preclinical and clinical evidence.
Area of Science:
- Biochemistry
- Vascular Biology
- Pharmacology
Background:
- Thrombosis is a leading global cause of death.
- Sirtuin 1 (SIRT1) is an NAD+-dependent deacetylase involved in cellular regulation.
- SIRT1 modulates key pathways implicated in thrombosis, including endothelial activation, platelet aggregation, and coagulation.
Purpose of the Study:
- To review the role of SIRT1 in thrombosis.
- To critically assess preclinical and clinical studies investigating SIRT1 as a therapeutic target for thrombosis.
Main Methods:
- Literature review of preclinical (in vitro, in vivo) and clinical studies.
- Analysis of SIRT1's impact on thrombosis-related pathways.
- Evaluation of SIRT1's anti-inflammatory and antioxidant effects.
Main Results:
- SIRT1 plays a significant role in regulating thrombosis.
- SIRT1 exhibits anti-inflammatory properties, partly through reducing oxidative stress.
- Targeting SIRT1 has demonstrated therapeutic potential in preventing thrombosis.
Conclusions:
- SIRT1 is a key regulator in thrombosis pathogenesis.
- Modulating SIRT1 activity presents a promising therapeutic strategy for thrombosis prevention.
- Further research is warranted to fully elucidate SIRT1's clinical applications in managing thrombotic disorders.
Abstract:
Thrombosis is a major cause of morbidity and mortality worldwide, with a complex and multifactorial pathogenesis. Recent studies have shown that SIRT1, a member of the sirtuin family of NAD + -dependent deacetylases, plays a crucial role in regulating thrombosis, modulating key pathways including endothelial activation, platelet aggregation, and coagulation. Furthermore, SIRT1 displays anti-inflammatory activity both in vitro, in vivo and in clinical studies, particularly via the reduction of oxidative stress. On these bases, several studies have investigated the therapeutic potential of targeting SIRT1 for the prevention of thrombosis. This review provides a comprehensive and critical overview of the main preclinical and clinical studies and of the current understanding of the role of SIRT1 in thrombosis.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Intracellular Signaling Affects Focal Adhesions
Some...
Clot Retraction and Fibrinolysis

